2m 2m 2m 2m 2m 2m 2m
BETA BIONICS (BBNX)
NASDAQ
$19.61+$0.56 (+2.94%)
Price as of Aug 21, 2026 8:00 PM EDT- $857.1MMarket Cap
- 11.73%1-Year Change
- Medical DevicesIndustry
BETA BIONICS (BBNX)
$19.61+$0.56 (+2.94%)
BBNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $19.05 | ||
Change | -$0.43 (-2.21%) | ||
Open | $19.50 | ||
High | $19.54 | ||
Low | $18.54 | ||
Previous Close | $19.48 | ||
Volume | 496,579 | ||
30-Day Average Volume | 1,443,961 | ||
1-Week Change | 8.42% | ||
1-Month Change | 8.12% | ||
1-Year Change | 11.73% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 45.0M | ||
Total Assets | $292.4M | ||
Market Cap | $857.1M | ||
Enterprise Value | $812.7M | ||
Period: QTR TTM FY | |||
Revenue | $32.0M | ||
Net Income | -$23.4M | ||
Free Cash Flow | -$15.7M | ||
EBIT | -$23.4M | ||
EBITDA | -$22.7M | ||
Net Working Capital | $205.0M | ||
EPS | -$0.53 | ||
Enterprise Value/EBITDA | -36 | ||
Enterprise Value/Revenue | 25 | ||
P/B | 3 | ||
P/E | -36 | ||
PEG | 4 | ||
Price/Free Cash Flow | -55 | ||
Price/Operating Cash Flow | -59 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue